期刊文献+

赖氨肌醇维生素B_(12)和葡萄糖酸钙锌口服液联合治疗手足口病后脱甲的疗效观察 被引量:1

Observation on Efficacy of Lysine Inositol Vitamin B_(12) Combined with Calcium and Zinc Gluconates Oral Liquid in Treatment of Defluvium Unguium of Hand-foot-mouth Disease
下载PDF
导出
摘要 目的:探讨赖氨肌醇维生素B_(12)和葡萄糖酸钙锌口服液联合治疗手足口病后脱甲的临床疗效及可行性。方法:选取2016年10月至2017年12月佛山市三水区妇幼保健院收治的手足口病后脱甲患儿40例,按随机数字表法分为观察组和对照组,每组20例。对照组患儿给予常规治疗,观察组患儿在对照组基础上加用赖氨肌醇维生素B_(12)和葡萄糖酸钙锌口服液联合治疗。观察两组患儿脱甲停止时间、家属满意度、随访1个月的痊愈情况及不良反应发生情况。结果:观察组患儿平均脱甲停止时间为(15.8±4.8)d,明显短于对照组的(23.4±6.2)d,差异有统计学意义(P<0.05);观察组患儿家属的满意率为90%(18/20),明显高于对照组的50%(10/20),差异有统计学意义(P<0.05);随访1个月后,观察组患儿的痊愈率为80%(16/20),明显高于对照组的45%(9/20),差异有统计学意义(P<0.05);两组患儿不良反应发生率的差异无统计学意义(P>0.05)。结论:赖氨肌醇维生素B_(12)和葡萄糖酸钙锌口服液联合治疗手足口病后脱甲患儿的疗效显著,且安全性较好。 OBJECTIVE: To probe into the clinical efficacy and feasibility of lysine inositol vitamin B_(12) combined with calcium and zinc gluconates oral liquid in treatment of defluvium unguium of hand-foot-mouth disease( HFMD).METHODS: 40 child patients with defluvium unguium of HFMD admitted into Foshan Sanshui District Maternal and Child Health Care Hospital from Oct. 2016 to Dec. 2017 were selected and divided into observation group and control group via random number table,with 20 cases in each. The control group was given conventional therapy,while the observation group was given lysine inositol vitamin B_(12) combined with calcium and zinc gluconates oral liquid. Stopping time of defluvium unguium,family members' satisfaction,recovery rates in 1-month follow-up and incidences of adverse drug reactions of two groups were observed. RESULTS: The average stopping time of defluvium unguium of observation group was( 15. 8 ± 4. 8) days,which was significantly shorter than that of the control group [( 23. 4 ± 6. 2) days],with statistically significant difference( P〈0. 05). Family members' satisfaction of observation group was 90%( 18/20),which was significantly higher than that of the control group( 50%,10/20),with statistically significant difference( P〈0. 05). After 1-month follow-up,the recovery rate of observation group was 80%( 16/20),which was significantly higher than that of the control group( 45%,9/20),with statistically significant difference( P〈0. 05). There was no statistical significance in difference of incidences of adverse drug reactions between two groups( P〉0. 05).CONCLUSIONS: The efficacy of lysine inositol vitamin B_(12) combined with calcium and zinc gluconates oral liquid in treatment of defluvium unguium of HFMD is remarkable,with high safety.
作者 邓琼晖 张健芳 苏金娣 DENG Qionghui;ZHANG Jianfang;SU Jindi(Dept.of Pediatric,Foshan Sanshui District Maternal and Child Health Care Hospital,Guangdong Foshan 528100,China)
出处 《中国医院用药评价与分析》 2018年第7期885-886,889,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 赖氨肌醇维生素B12 葡萄糖酸钙锌口服液 手足口病后脱甲 Lysine inositol vitamin B12 Calcium and zinc gluconates oral liquid Defluvium unguium of HFMD
  • 相关文献

参考文献9

二级参考文献63

  • 1赵辩.中国临床皮肤病学[M].南京:江苏科学技术出版社,2010:1527.
  • 2胡亚美,诸福堂.实用儿科学[M].7版.北京:人民卫生出版社,2002:1174
  • 3吕连菊.丽珠肠乐与赖氨肌醇维B_(12)口服液联合治疗小儿厌食临床观察[J].白求恩军医学院学报,2007,5(6):348-348. 被引量:4
  • 4Bernier V, Labrèze C, Bury F, et al. Nail matrix arrest in the course of hand, foot and mouth disease[J]. Eur J Pediatr,2001,160(11):649-651.
  • 5Cabrerizo M, De Miguel T, Armada A, et al. Onychomadesis after a hand, foot, and mouth disease outbreak in Spain,2009[J]. Epidemiol Infect,2010,138(12):1775-1778.
  • 6Shikuma E, Endo Y, Fujisawa A, et al. Onychomadesis developed only on the nails having cutaneous lesions of severe hand-foot-mouth disease[J]. Case Rep Dermatol Med,2011,2011:Article ID 324193.
  • 7Wu Y, Yeo A, Phoon MC, et al. The largest outbreak of hand; foot and mouth disease in Singapore in 2008:the role of enterovirus 71 and coxsackievirus a strains[J]. Int J Infect Dis,2010,14(12):e1076-e1081.
  • 8Wei SH, Huang YP, Liu MC, et al. An outbreak of coxsackievirus A6 hand, foot, and mouth disease associated with onychomadesis in Taiwan,2010[J]. BMC Infect Dis,2011,11(346):1471-2334.
  • 9Davia JL, Bel PH, Ninet VZ, et al. Onychomadesis outbreak in valencia, spain associated with hand, foot, and mouth disease caused by enteroviruses[J]. Pediatr Dermatol,2011,28(1):1-5.
  • 10Osterback R, Tytti V, Mervi L, et al. Coxsackievirus A6 and hand, foot, and mouth disease, Finland[J]. Emerg Infect Dis,2009,15(9):1485-1488.

共引文献65

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部